Breaking News Instant updates and real-time market news.

NUVA

NuVasive

$61.01

0.09 (0.15%)

08:33
01/08/18
01/08
08:33
01/08/18
08:33

NuVasive sees Q4 revenue $272M, consensus $272.9M

The company states: "NuVasive preliminary revenue results for full year 2017 reflect approximately 7% growth on a reported and constant currency basis, compared to revenue of $962 million for 2016. When NuVasive updated its full year 2017 financial guidance on Oct. 24 to reflect third-quarter 2017 results, the company assumed international revenue growth of over 20 percent, a lingering impact of Hurricane Maria in Puerto Rico in the fourth quarter and softer U.S. procedural volumes continuing into the fourth quarter. Those assumptions have remained unchanged."

  • 08

    Jan

NUVA NuVasive
$61.01

0.09 (0.15%)

12/15/17
PIPR
12/15/17
NO CHANGE
Target $90
PIPR
Overweight
NuVasive's new lateral ALIF system underappreciated, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien views NuVasive's new lateral anterior lumbar interbody fusion procedure as an underappreciated revenue driver for the company. This as an important introduction for NuVasive as it finally allows the company to access the lower lumbar region with less invasiveness, O'Brien tells investors in a research note. He notes the product will allow NuVasive to compete head-to-head with Medtronic's (MDT) OLIF procedure, which he believes has grown quickly. O'Brien sees the lateral ALIF system adding $30M-$50M to NuVasive sales over the next three to four years, helping to push the stock higher. He keeps an Overweight rating on the stock with a $90 price target.
12/21/17
JPMS
12/21/17
NO CHANGE
JPMS
Overweight
NuVasive among biggest beneficiaries in MedTech from tax reform, says JPMorgan
JPMorgan analyst Robbie Marcus noted that NuVasive announced that it estimates tax law changes should drop its non-GAAP tax rate into the "low 20% range" in 2018, which he said makes it one of the biggest beneficiaries in the MedTech sector from U.S. tax reform. However, he also thinks the tax benefits have been well telegraphed and that much of the expected benefit is already factored into the stock. He maintains an Overweight rating on NuVasive shares.
12/28/17
PIPR
12/28/17
NO CHANGE
PIPR
Piper says own K2M, NuVasive into January conference
Piper Jaffray analyst Matt O'Brien recommends owning shares of K2M Group (KTWO) and NuVasive (NUVA) into a competitor conference that begins on January 8. The analyst is cautious on Zimmer Biomet (ZBH) into the conference. K2M and NuVasive are names to own going into the conference as both will meet or beat Q4 revenue estimates, O'Brien tells investors in a research note. He sees a favorable 2018 outlook for both companies as well as room for multiple expansion. On Zimmer, which the analyst downgraded recently, O'Brien continues to believe the company's turnaround will take longer than investors realize.
01/04/18
NEED
01/04/18
UPGRADE
Target $71
NEED
Buy
NuVasive upgraded to Buy from Underperform at Needham
As reported earlier, Needham analyst Mike Matson upgraded NuVasive two notches, to Buy from Underperform, and set a $71 price target on the shares. Matson says consensus revenue and EPS estimates have declined to more realistic and "likely conservative" levels, while the company's acquisitions of Vertera and SafePassage are likely not factored into consensus. The analyst also expects a 15% increase in NuVasive EPS as a result of the "significant benefit" from lower U.S. corporate tax rates.

TODAY'S FREE FLY STORIES

MU

Micron

$46.02

0.97 (2.15%)

, SCS

Steelcase

$15.90

0.6 (3.92%)

14:51
09/20/18
09/20
14:51
09/20/18
14:51
Earnings
Notable companies reporting after market close »

Notable companies…

MU

Micron

$46.02

0.97 (2.15%)

SCS

Steelcase

$15.90

0.6 (3.92%)

UNFI

United Natural Foods

$33.65

0.36 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 25

    Sep

  • 28

    Oct

WFC

Wells Fargo

$55.64

0.41 (0.74%)

14:50
09/20/18
09/20
14:50
09/20/18
14:50
Hot Stocks
Wells Fargo sees headcount down approximately 5%-10% in next three years »

Wells Fargo announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 21

    Oct

  • 12

    Apr

  • 13

    Jul

  • 15

    Oct

14:50
09/20/18
09/20
14:50
09/20/18
14:50
General news
Canada retail sales preview »

Canada retail sales…

14:50
09/20/18
09/20
14:50
09/20/18
14:50
General news
Canada CPI preview »

Canada CPI preview: CPI,…

MU

Micron

$45.96

0.91 (2.02%)

14:49
09/20/18
09/20
14:49
09/20/18
14:49
Options
Micron options imply 11.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

WFC

Wells Fargo

$55.65

0.42 (0.76%)

14:48
09/20/18
09/20
14:48
09/20/18
14:48
Hot Stocks
Breaking Hot Stocks news story on Wells Fargo »

Wells Fargo sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 21

    Oct

  • 12

    Apr

  • 13

    Jul

  • 15

    Oct

CRBP

Corbus Pharmaceuticals

$7.80

2.65 (51.46%)

14:45
09/20/18
09/20
14:45
09/20/18
14:45
Periodicals
Feuerstein says 'doesn't get much dumber' than Corbus being up 50% after deal »

Adam Feuerstein of STAT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 01

    Oct

MDT

Medtronic

$97.45

0.99 (1.03%)

14:40
09/20/18
09/20
14:40
09/20/18
14:40
Options
One day call buyers in Medtronic »

One day call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

DUK

Duke Energy

$80.52

0.45 (0.56%)

14:37
09/20/18
09/20
14:37
09/20/18
14:37
Hot Stocks
Duke says natural gas combined cycle plant at Sutton continues to operate safely »

Duke Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 11

    Nov

KRYS

Krystal Biotech

$17.00

0.45 (2.72%)

14:36
09/20/18
09/20
14:36
09/20/18
14:36
Conference/Events
Krystal Biotech management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 01

    Oct

14:35
09/20/18
09/20
14:35
09/20/18
14:35
General news
U.S. Household net worth rose »

U.S. Household net worth…

PENN

Penn National

$32.37

0.16 (0.50%)

, PNK

Pinnacle Entertainment

$33.42

0.09 (0.27%)

14:33
09/20/18
09/20
14:33
09/20/18
14:33
Hot Stocks
Penn National reports Colorado gaming approval from for Pinnacle acquisition »

Penn National Gaming…

PENN

Penn National

$32.37

0.16 (0.50%)

PNK

Pinnacle Entertainment

$33.42

0.09 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:28
09/20/18
09/20
14:28
09/20/18
14:28
Conference/Events
Morgan Stanley household products analyst holds analyst/industry conference call »

Household Products,…

ALB

Albemarle

$106.69

1.2 (1.14%)

14:27
09/20/18
09/20
14:27
09/20/18
14:27
Recommendations
Albemarle analyst commentary  »

Loop Capital would still…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

AMZN

Amazon.com

$1,947.74

21.47 (1.11%)

14:23
09/20/18
09/20
14:23
09/20/18
14:23
Periodicals
Amazon says the Echo Auto will cost $50 »

According to a live blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ACAD

Acadia

$18.47

3.36 (22.24%)

14:21
09/20/18
09/20
14:21
09/20/18
14:21
Recommendations
Acadia analyst commentary  »

FDA safety communication…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

LUV

Southwest

$62.95

-0.16 (-0.25%)

14:20
09/20/18
09/20
14:20
09/20/18
14:20
Periodicals
Former Southwest employee alleges racial discrimination, Dallas News says »

A former Southwest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 06

    Nov

ARRY

Array BioPharma

$14.75

-0.015 (-0.10%)

14:20
09/20/18
09/20
14:20
09/20/18
14:20
Hot Stocks
Array BioPharma says EU approves BRAFTOVI, MEKTOVI combo »

Array BioPharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

AMZN

Amazon.com

$1,948.94

22.67 (1.18%)

14:19
09/20/18
09/20
14:19
09/20/18
14:19
Periodicals
Amazon unveils Echo Auto to bring Alexa to cars »

According to a live blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
09/20/18
09/20
14:17
09/20/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
09/20/18
09/20
14:16
09/20/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,949.08

22.81 (1.18%)

14:15
09/20/18
09/20
14:15
09/20/18
14:15
Periodicals
Amazon unveils Fire TV Recast »

According to a live blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

GE

General Electric

$12.44

-0.42 (-3.27%)

, EXC

Exelon

$43.32

0.09 (0.21%)

14:13
09/20/18
09/20
14:13
09/20/18
14:13
Periodicals
Exelon Generation COO confirms GE blade issue in Bloomberg interview »

Exelon Generation (EXC)…

GE

General Electric

$12.44

-0.42 (-3.27%)

EXC

Exelon

$43.32

0.09 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 11

    Nov

AMZN

Amazon.com

$1,947.47

21.2 (1.10%)

14:11
09/20/18
09/20
14:11
09/20/18
14:11
Periodicals
Amazon's new Echo Show has Hulu, Meal Kits capabilities »

According to a live blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

LYV

Live Nation

$52.28

-0.41 (-0.78%)

14:10
09/20/18
09/20
14:10
09/20/18
14:10
Options
Call buyers in LiveNation as shares rally off session lows »

Call buyers in LiveNation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.